Nephrology

Latest News

scientific image of kidney | image credit: ©crystal light
FDA Approves Novartis’ Oral Fabhalta as First Treatment for C3G

March 21st 2025

This is the third approval for Fabhalta (iptacopan), which was discovered and developed by Novartis.

boy and mom speaking with HCP with a model of a kidney in the foreground | image credit: ©Peakstock stock.adobee.com
Lurie Chicago Children’s Hospital Expands 24/7 In-House Dialysis Nursing Coverage

March 17th 2025

dialysis machine w patient in the background wearing blue | image credit: @Александр Ивасенко stock.adobe.com
New Guidance for Managing People With Acute Kidney Injury Requiring Outpatient Dialysis

March 14th 2025

mbruxelle-stock.adobe.com
FDA Approves Ozempic to Reduce Kidney Disease in Type 2 Diabetes

January 28th 2025

Furthering Managed Care Through Advances in IgA Nephropathy Therapy
Furthering Managed Care Through Advances in IgA Nephropathy Therapy

September 24th 2024

More News

Looking to the Future of IgA Nephropathy Treatment

Looking to the Future of IgA Nephropathy Treatment

September 24th 2024

A Q&A with Jonathan Barratt, Ph.D., FRCP.

Read More

tashatuvango-stock.adobe.com

FDA Approves Vafseo for Anemia in Kidney Disease

Denise Myshko
March 28th 2024

Vafseo, an oral therapy to treat patients with anemia due to chronic kidney, will be available in January 2025. About 40% of patients who could be treated with Vafseo have coverage through Medicare Advantage plans.

Read More

Mixed Verdict on ESRD ACOs

Mixed Verdict on ESRD ACOs

Peter Wehrwein;Peter Wehrwein, Managing Editor
March 4th 2022

How successful accountable care organizations (ACOs) have been in bringing about value-based care hinges, of course, on how success is defined. CMS’ comprehensive end-stage renal disease (ESRD) care model is a good example.

Read More

© 2025 MJH Life Sciences

All rights reserved.